← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2001Last known activity
Nov 30, 2025
Timeline
2000s
- Jan 1, 2001
The Swedish Research Council— Founded
Drugs by trial phase (74 distinct, 47 trials)
Phase 4 (15 own, 0 via acquisition)
Phase 3 (33 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Acute Kidney Injury
- Acute Lung Injury
- Anemia, Iron-Deficiency
- Angina, Unstable
- Arthritis
- Arthritis, Rheumatoid
- Birth Weight
- Carcinoma
- Carcinoma, Ovarian Epithelial
- Carcinoma, Squamous Cell
- Child Behavior Disorders
- Cicatrix
- Colorectal Neoplasms
- Compulsive Personality Disorder
- Critical Illness
- Dental Caries
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Eczema
- Esophageal Squamous Cell Carcinoma
- Hepatitis
- Hepatitis C
- Hypersensitivity
- Infarction
- Leukemia
- Leukemia, Lymphoid
- Lung Injury
- Mental Disorders
- Multiple Sclerosis
- Myocardial Infarction
- Neoplasms
- Neurobehavioral Manifestations
- Non-ST Elevated Myocardial Infarction
- Obesity
- Obsessive-Compulsive Disorder
- Ovarian Neoplasms
- Parkinson Disease
- Peri-Implantitis
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Prostatic Neoplasms
- Prostatic Neoplasms, Castration-Resistant
- Rectal Neoplasms
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Respiratory Insufficiency
- Sclerosis
- ST Elevation Myocardial Infarction
- Stroke
- Syndrome
- Urinary Bladder Neoplasms
- Uterine Cervical Neoplasms
- Virus Diseases
Recent trials (47)
- NCT07236944CollaboratorPhase 4Nov 30, 2025
- NCT06515730CollaboratorPhase 4Oct 1, 2024
- NCT06033131CollaboratorPhase 3Jan 22, 2024
- NCT05852704CollaboratorPhase 4Oct 2, 2023
- NCT05939076CollaboratorPhase 3Aug 21, 2023
- NCT05764746CollaboratorPhase 2/Phase 3Apr 1, 2023
- NCT05169229CollaboratorPhase 2/Phase 3Apr 1, 2022
- NCT05241327CollaboratorN/AJan 1, 2022
- NCT05182970CollaboratorPhase 3Dec 2, 2021
- NCT05600517CollaboratorN/AAug 25, 2021
- NCT04920149CollaboratorPhase 2Aug 9, 2021
- NCT04561986CollaboratorPhase 4Jan 31, 2021
- NCT04460352CollaboratorPhase 3Nov 27, 2020
- NCT04534075CollaboratorPhase 3Sep 2, 2020
- NCT04327505CollaboratorPhase 2/Phase 3Apr 25, 2020
Details
- Founded
- Stockholm, SE Jan 1, 2001
- Last known activity
- Nov 30, 2025